AmbioPharm, Inc. (APi) is a full-service peptide manufacturing company headquartered in North Augusta, SC, USA. In our cGMP manufacturing facilities in the USA and Shanghai, China, we develop highly efficient processes for manufacturing peptides at small to very large scale as Active Pharmaceutical Ingredients used in New Chemical Entities and generic peptides by clients worldwide.
Contact our team of experts to place an inquiry.
Browse our brochures to learn more about AmbioPharm.
CHI Europe // October 9-11, 2018
Booth // Madrid, Spain
Schedule an Appointment with our Experts
Peptide Therapeutics Symposium // October 25-26, 2018
Attendance Only // La Jolla, CA
Schedule an Appointment with our Experts
Bio Europe // November 5-7, 2018
Attendance only, Copenhagen, Denmark
Schedule an Appointment with our Experts
Eurotides // November 5-9, 2018
Attendance only, Amsterdam, Holland
Schedule an Appointment with our Experts
December 6, 2018
Press Release
AmbioPharm Continues Construction and Facility Expansions
November 28, 2018
Press Release
AmbioPharm Inc. Hires New Senior Director of Peptide Manufacturing
October 4, 2018
Press Release
AmbioPharm Inc. Promotes New CSO
September 10, 2018
Article
The Carlyle Group Acquires Significant Minority Stake in Ambio